Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript

Rockwell Medical (RMTI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactu

Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.04) per share which beat the analyst

Rockwell Medical (NASDAQ:RMTI) affirms FY2026 sales outlook from $70.000 million-$75.000 million to

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q2'26 res

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likel

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Brian Cox joins Rockwell Medical as

Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, ma

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical received notice fro

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its re

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with

Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, ma

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's Board of Director

Rockwell Medical (RMTI) spikes 6.4% premarket. Discover key support and resistance levels as the sto

The Agreement, which includes supply and purchasing commitments, will be in effect for two years wit

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply aQua Di

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactu

Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, ma

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply Heritag

Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call Transcript

Rockwell Medical (RMTI) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus

Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual GuidanceNet Sales$70.0M to

Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.01) per share which beat the analyst

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical 2026 Guidance is ce

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its re

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

If you are looking for stocks that have gained strong momentum recently but are still trading at rea

Rockwell Medical, Inc. (RMTI) Q4 2025 Earnings Call Transcript

Rockwell Medical (RMTI) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus

GUIDANCEFor the third year in a row, Rockwell Medical's annual performance was directly in line

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with

Rockwell Medical (RMTI) stock rose after announcing preliminary Q4 and full-year 2025 financial resu

Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial HighlightsThe Company expects net

Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, ma

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with

Rockwell Medical (NASDAQ:RMTI) affirms FY2025 sales outlook from $65.000 million-$70.000 million to

Rockwell Medical (NASDAQ:RMTI) reported quarterly sales of $15.927 million which missed the analyst